ArticleTransplantation direct2023

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression.

V Ram Peddi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.